Therapy Areas: Central Nervous System
13 February 2024 - Nuvalent, Inc. (Nasdaq: NUVL), a US-based clinical-stage biopharmaceutical company, announced on Monday that it has started the phase two part of ALKOVE-1, its Phase 1/2 clinical tr...
23 January 2024 - GC Biopharma Corp. (006280.KS), a South Korea-based biopharmaceutical company, announced on Monday that it has received Orphan Drug Designation (ODD) from the European Medicines Agen...
11 January 2024 - Guangzhou Fermion Technology Co., Ltd. (Fermion), a China-based clinical-stage AI-based drug discovery company that specializes in developing drugs for autoimmune diseases and pain, ...
29 December 2023 - Italian biopharmaceutical company Newron Pharmaceuticals S.p.A. (SIX:NWRN) (XETRA:NP5) announced on Friday that it has completed patient enrolment in its potentially pivotal study o...
27 December 2023 - Vistagen (Nasdaq:VTGN), a late clinical-stage biopharmaceutical company focused on anxiety, depression and other central nervous system (CNS) disorders, said on Wednesday that it ha...
27 December 2023 - GenSight Biologics (Euronext: SIGHT, a biopharmaceutical company that develops and commercialises gene therapies for retinal neurodegenerative diseases and central nervous system di...